LIFESPHERE® CLINICAL
eCOA
Intuitive and unified electronic clinical outcomes assessment.
JUMP TO
Improves protocol compliance and data quality.
LifeSphere eCOA is an intuitive and unified electronic clinical outcome assessment (eCOA) solution for clinical trials that allow patients to enter data directly on any mobile device.
BENEFITS
Engage Patients
Involve patients in their own care, ensuring better adherence to protocols.
Simplify Clinical Trials
Eases patient acceptance of ePRO via the use of familiar devices and an intuitive user interface.
Accelerate Alerts
Improves patient monitoring and safety through real-time reporting and provide automated alert notifications to patients.
FACT SHEET
Intuitive and Unified Electronic Clinical Outcomes Assessment
LifeSphere eCOA is an intuitive and unified electronic clinical outcome assessment (eCOA) solution for clinical trials that allow patients to enter data directly on any mobile device.
WHITEPAPER
Getting Connected: The Benefits of a Unified Clinical Platform
As the pressure to achieve faster, most cost-effective results, and to tap into new technologies to expand capabilities mounts, clinical operations will need a more progressive approach to managing every aspect of the clinical trial. A unified platform is the way forward.
BLOG
The Clinical Domain is Evolving. Make Sure your CTMS is Evolving with It.
The Evolving Role of CTMS in Risk Management takes a broad look at the challenges facing clinical trial management, how the clinical domain is changing, and how the industry can better respond.
FEATURES
Improve Efficiency, Productivity, and Cost Savings.
Improved Compliance
LifeSphere eCOA increases protocol compliance and improves data quality by allowing subjects to respond in real-time.
Effortless Integration
For complete automation and to mitigate redundant data entry LifeSphere eCOA is fully integrated with other clinical systems.
Real-Time Capabilities
LifeSphere eCOA captures and delivers real-time updates to allow sponsors and contract research organizations (CROs) to feel confident with evaluating drug effects based on patient responses and enable them to quickly respond to serious adverse events, protocol violations and deviations.
RESULTS
Delivering Real Results to a Global Client Base
80
%
Global Colaboration
80% of the top 50 pharma companies are our clients
80
%
Efficiency Gains
80% potential efficiency gains driven by our Nava cognitive computing engine
30
%
Cost Savings
30% immediate cost savings potential via our advanced automation capabilities
100
%
Compliance
100% compliance with all present and upcoming regulatory standards
PARTNERS
Partnering With the Industry’s Best
